Changing consumer trends and market dynamics are leading to hundreds of pharmacy store closures in the U.S.

College Station-based Texas A&M University researchers are developing a way to 3D-print pediatric medications for toxoplasmosis, an infection caused by parasites.

San Francisco-based UCSF Health opened new retail pharmacies at its Mission Bay and Parnassus, Calif., campuses, offering comprehensive and accessible health services. 

A new survey by the National Community Pharmacists Association found that more than 90% of independent pharmacists may refuse to sell drugs targeted by Medicare Part D negotiations, potentially jeopardizing the Biden administration's efforts to lower prescription costs. 

A new study suggests that Medicare could save up to $366 million annually by introducing a new vial size for Alzheimer's drug lecanemab, which is currently only available in single-use, 500- and 200-milligram vials. 

The FDA has granted another exemption from certain requirements of the Drug Supply Chain Security Act to help eligible trading partners address challenges with data exchange while ensuring patient access to medications. 

GSK announced positive results from two phase 3 clinical trials evaluating its experimental drug, depemokimab, for chronic rhinosinusitis with nasal polyps affecting 4% of the population. 

Sanofi is entering negotiations with Clayton, Dublier & Rice regarding the potential sale of a 50% controlling stake in its consumer health business, Opella. 

Massachusetts pharmacist Glenn Chin was sentenced Oct. 11 in Michigan to 7 1/2 to 15 years in prison for his involvement in a 2012 meningitis outbreak that led to 11 deaths in Michigan and dozens more across the country, The…

The FDA has decided to reconsider its recent ban on the sale of compounded versions of tirzepatide, according to court documents obtained by Becker's.